Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dopamine autoreceptor agonists including CGS 15855A decrease dopamine release and metabolism in mouse brain.

C A Altar, W C Boyar, P L Wood

    European Journal of Pharmacology
    |February 24, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Obstetric and gynaecology trainees' knowledge of paediatric and adolescent gynaecology services in the UK: A national qualitative thematic analysis.

    European journal of obstetrics, gynecology, and reproductive biology·2019
    Same author

    An integrative taxonomic review of the agamid genus Bronchocela (Kuhl, 1820) from Peninsular Malaysia with descriptions of new montane and insular endemics.

    Zootaxa·2015
    Same author

    Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes.

    The pharmacogenomics journal·2015
    Same author

    A new species of Hemiphyllodactylus Bleeker, 1860 (Squamata: Gekkonidae) from Ba Na-Nui Chua Nature Reserve, Central Vietnam.

    Zootaxa·2014
    Same author

    WIN 44,441: A Stereospecific and Long-Acting Narcotic Antagonist.

    Pharmaceutical research·2013
    Same author

    Is it time to actively look for vasa praevia?

    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2012

    Dopamine autoreceptor agonists suppress dopamine release and metabolism in mice, providing neurochemical evidence for these receptors. The novel agonist CGS 15855A demonstrated sustained effects without tolerance.

    Area of Science:

    • Neuropharmacology
    • Neurochemistry
    • Dopaminergic system research

    Background:

    • Dopamine autoreceptors regulate dopamine release and metabolism.
    • Evidence for dopamine autoreceptors in mice was previously lacking.
    • Understanding autoreceptor function is crucial for dopaminergic system modulation.

    Purpose of the Study:

    • To provide neurochemical evidence for dopamine autoreceptors in the mouse brain.
    • To investigate the effects of various dopamine autoreceptor agonists on dopamine release and metabolism.
    • To characterize the pharmacological specificity and duration of action of the novel agonist CGS 15855A.

    Main Methods:

    • Measurement of steady-state levels of 3-methoxytyramine (3-MT), dihydroxyphenylacetic acid (DOPAC), and homovanillic acid (HVA) in mouse brain.

    Related Experiment Videos

  • Administration of dopamine autoreceptor agonists, including CGS 15855A, to assess their impact on dopamine metabolites.
  • Comparison of agonist potency and efficacy across different dopamine metabolites and brain regions (striatum, limbic).
  • Main Results:

    • Several dopamine autoreceptor agonists, including CGS 15855A, decreased 3-MT levels, indicating suppressed dopamine release and metabolism.
    • CGS 15855A demonstrated comparable efficacy in both rat and mouse neostriatum and showed sustained suppression of dopamine release/metabolism for over 3.5 hours without acute tolerance.
    • The (+) optical isomer of CGS 15855A was responsible for the autoreceptor efficacy, and effects on 3-MT were more pronounced than on DOPAC or HVA.

    Conclusions:

    • The study provides the first neurochemical evidence for functional dopamine autoreceptors in the mouse brain.
    • Dopamine release and metabolism in mouse limbic and striatal regions are regulated by autoreceptors with similar pharmacological properties to those in rats.
    • The novel agonist CGS 15855A is a potent and effective dopamine autoreceptor agonist with sustained action, offering potential for further research.